How to Help Your Patients Find Griseofulvin In Stock: A Provider's Guide

As a prescriber, few things are more frustrating than a patient calling your office the same day of their appointment to report they can't fill the prescription you just wrote. For griseofulvin — particularly the oral suspension used in pediatric tinea capitis — this scenario is common. This guide gives you a structured approach to reducing prescription abandonment and accelerating treatment initiation for your patients.

Why Patients Can't Fill Griseofulvin Prescriptions

Griseofulvin is not in an active FDA shortage as of 2026, but it's a niche, low-volume generic antifungal that many retail pharmacies don't routinely stock. The issue is particularly acute for the oral suspension (125 mg/5 mL), which is critical for young children with tinea capitis. The reasons are straightforward:

Low prescription volume means most chain pharmacies don't keep it in their standard inventory cycle

The suspension has a shorter shelf life, making stocking it a financial risk for pharmacies that don't see regular demand

Multiple formulations (microsize vs. ultramicrosize) and strengths create confusion in inventory ordering

Supply chain tightness for generic pharmaceuticals affects restocking speed

Step 1: Build the Pharmacy Check Into Your Visit Workflow

The most effective intervention happens before the patient leaves your office. Train your front desk or medical assistant staff to call the patient's preferred pharmacy to verify griseofulvin stock before the e-prescription is sent. This takes 2–3 minutes and can save the patient an entire afternoon of frustration.

Instruct staff to ask the pharmacy specifically: "Do you have griseofulvin [microsize 500 mg tablets / ultramicrosize 250 mg tablets / suspension 125 mg/5 mL] in stock and available to fill today?" Being specific about the formulation is critical because a pharmacy may have one form but not another.

Step 2: Write Flexible Prescriptions When Clinically Appropriate

When writing a griseofulvin prescription, consider noting acceptable formulation alternatives. For example, if the patient is an older child or adult who can swallow tablets, note that both microsize and ultramicrosize formulations are acceptable. This gives the pharmacist flexibility to dispense whichever formulation they have in stock without requiring a new prescription.

For pediatric patients requiring the suspension, you may also consider prescribing the tablets with instructions to crush and mix in a fatty food if the child is old enough and the formulation change is clinically appropriate. Confirm this with the pharmacist before advising patients.

Step 3: Maintain Relationships with Local Compounding Pharmacies

For practices that regularly prescribe griseofulvin suspension — particularly pediatric clinics and dermatology offices — establishing a referral relationship with a local compounding pharmacy is invaluable. Compounding pharmacies can prepare griseofulvin suspension at the exact concentration ordered and often have shorter waits than waiting for a retail pharmacy to special-order it from a wholesaler.

Patients should be advised upfront that compounded medications may not be covered by insurance. Encourage them to call ahead to confirm pricing, which may be $30–$80 or more depending on the formulation and pharmacy.

Step 4: Use medfinder to Search Multiple Pharmacies Simultaneously

For patients who have already left your office, direct them to medfinder's provider resource page. medfinder is a paid service that calls pharmacies near the patient to check which ones have a specific medication in stock, then texts results directly to the patient. This eliminates the need for patients to spend hours calling pharmacies themselves — which is particularly important for busy parents of young children with tinea capitis.

Step 5: Have an Alternative Ready Before the Patient Asks

If you're prescribing griseofulvin in an area where you know availability is problematic, consider preparing an alternative prescription simultaneously — only to be filled if griseofulvin cannot be located within 48 hours. For most pediatric tinea capitis caused by Trichophyton tonsurans, oral terbinafine is a reasonable alternative with strong efficacy data and good tolerability in children. Document this contingency plan in the patient's chart.

Adjunctive Measures While Awaiting Medication

For pediatric tinea capitis patients, clinical guidelines support adjunctive use of selenium sulfide or ketoconazole shampoo twice weekly alongside oral therapy. These shampoos reduce spore shedding and may limit transmission to other household members. Advising parents to begin this while they search for the oral medication is a practical step to reduce contagion while awaiting definitive therapy.

Special Considerations for Nail Infection Patients

Patients being treated for onychomycosis with griseofulvin require continuous medication for 6–18 months. Mid-course disruptions due to unavailability can lead to treatment failure and reinfection. For these patients, consider:

Writing 90-day supplies to reduce the frequency of potential stock-out events

Directing patients to mail-order pharmacies through their insurance plan, which may have more reliable stock

Considering a switch to terbinafine or itraconazole at the next visit if griseofulvin access remains problematic — both are superior for onychomycosis in most respects and have better pharmacy stock penetration

Patient Communication Script

When handing a patient a griseofulvin prescription, consider providing a brief verbal or written message such as: "Griseofulvin may not be at your usual pharmacy — it's a specialty medication not every pharmacy keeps in stock. Please call ahead before going, or use the medfinder service to find where it's available near you. If you can't find it within 2 days, call us back and we'll discuss next steps."

For more on the current availability landscape, see our post on what providers need to know about the griseofulvin shortage in 2026.